COVID-19's Impact on Anxiety in France Shows No Lasting Increase

A study published by Santé publique France on July 22, 2025, reveals that anxiety disorders among the French population did not exhibit a sustainable increase following the COVID-19 pandemic. Despite an initial spike in anxiety symptoms early in the pandemic, the prevalence remained stable at 12.5% from 2017 to 2021. Researchers noted that while anxiety symptoms surged temporarily during the pandemic's onset, this did not translate into a lasting rise in anxiety disorders, contrasting with the sustained increase in depressive episodes observed during the same period.

The findings suggest that financial difficulties and lower educational levels are significant factors influencing the prevalence of anxiety among individuals. Those facing economic hardship reported higher levels of anxiety, indicating that socioeconomic conditions played a critical role in mental health outcomes during and after the crisis.

This study challenges earlier assumptions about the pandemic's long-term effects on anxiety disorders and places emphasis on the importance of addressing financial and educational disparities to support mental health in France.

The health study underscores the necessity for public health initiatives to focus on these vulnerable populations to combat anxiety effectively, reflecting a nuanced understanding of mental health dynamics in the wake of the pandemic.

As public health officials continue to analyze pandemic impacts, these insights may shape future mental health policies in France.